| Outcome Measures: |
Primary: Change from baseline the rate of production of VLDL Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the rate of production of IDL Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the rate of production of LDL Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the rate of production of HDL Apo A1, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the Fractional Catabolic Rate of VLDL1 Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the Fractional Catabolic Rate of VLDL2 Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the Fractional Catabolic Rate of IDL Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the Fractional Catabolic Rate of LDL Apo B, 15 days before treatment initiation, Day 0, Day 90 and Day 180|Change from baseline the Fractional Catabolic Rate of HDL 'Apo A1, 15 days before treatment initiation, Day 0, Day 90 and Day 180 |
|
